Global Chemical API CDMO Market Research Report 2026

Industry: Service & Software

Published: 2026-01-15

Pages: 139 Pages

Report ld: 5683405

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Chemical API CDMO market was valued at US$ 27700 million in 2025 and is anticipated to reach US$ 46080 million by 2032, at a CAGR of 7.6% from 2026 to 2032.

Chemical API CDMO, or Contract Research and Manufacturing Organization, provides pharmaceutical companies with customized R&D and manufacturing services for active pharmaceutical ingredients (APIs) and related intermediates from preclinical to commercialization stages. Its services encompass process route development and optimization, analytical method establishment and validation, pilot-scale and intermediate-scale production, process safety assessment, and support for large-scale production and registration applications in compliance with Good Manufacturing Practices (GMP). This model, through specialized division of labor, helps clients reduce R&D costs, shorten development cycles, address the challenges of complex chemical synthesis and production scale-up, and ensure supply chain reliability and compliance. It is a key enabling link in the supply chain for innovative chemical drugs and complex generic drugs.

Chemical API CDMO Market Size(US$)

M= millions and B=billions

The cost structure of a Chemical API CDMO primarily includes human resources investment in R&D and process optimization, depreciation and energy consumption of GMP-compliant production facilities, procurement of key materials, and strict environmental and quality control costs. Its gross profit margin typically ranges from 25% to 45%, depending on the complexity of the technology, production scale, and capacity utilization. Projects with technological barriers, such as highly active APIs and continuous flow processes, can command significant premiums, while standardized products produced at scale rely on cost control and supply chain efficiency to maintain profits.

The global landscape of Chemical API CDMO presents a "dual-core, diversified evolution" pattern. The Asia-Pacific region, represented by China and India, is the world's largest production capacity center and supply chain hub. Leveraging its mature chemical engineering foundation, cost advantages, and continuously improving compliance levels, it dominates the mid-to-back-end large-scale production market. Europe and North America maintain technological leadership in cutting-edge process development, complex molecule production, and early-stage clinical projects, particularly in the high-activity, high-value-added API sector. Currently, the global industrial chain is undergoing rapid restructuring. The need for supply chain security and regional autonomy is driving a trend towards decentralized and near-shore production capacity. Meanwhile, technological innovations such as green chemistry and continuous manufacturing, along with regulatory upgrades in emerging markets, are jointly shaping a more resilient, efficient, and sustainable new industry ecosystem for the future.

This report delivers a comprehensive overview of the global Chemical API CDMO market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chemical API CDMO. The Chemical API CDMO market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Chemical API CDMO market comprehensively. Regional market sizes by Type, by Application, by Business Stage, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Chemical API CDMO manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Report Metric
Details
Report Title
Global Chemical API CDMO Market Research Report 2026
Forecasted Market Size in 2032
US$ 46080 million
CAGR(2026-2032)
7.6%
Market Size Available for Years
2026-2032
Global Chemical API CDMO Companies Covered
Flamma Group
HAS Healthcare
Asymchem
Recipharm
Pierre Fabre
Pfizer CentreOne
Axplora
Lonza
MAI CDMO
BioVectra
Curia
AGC Pharma Chemicals
Asymchem
Olon Group
Evonik Health Care
Teva Active Pharmaceutical Ingredients
Global Chemical API CDMO Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chemical API CDMO Market, Segment by Type
Small Molecule CDMO
Macromolecule CDMO
Cell Gene Therapy (CGT) CDMO
Global Chemical API CDMO Market, Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Product Category
Early-stage R&D CDMO
Clinical Stage CDMO
Commercial Production CDMO
Market Segment
Bulk/Standard API CDMO
Specialty API CDMO
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Business Stage, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Chemical API CDMO companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chemical API CDMO Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
        1.2.2 Small Molecule CDMO
        1.2.3 Macromolecule CDMO
        1.2.4 Cell Gene Therapy (CGT) CDMO
    1.3 Market by Business Stage
        1.3.1 Global Chemical API CDMO Market Size Growth Rate by Business Stage: 2021 vs 2025 vs 2032
        1.3.2 Early-stage R&D CDMO
        1.3.3 Clinical Stage CDMO
        1.3.4 Commercial Production CDMO
    1.4 Market by Product Technology
        1.4.1 Global Chemical API CDMO Market Size Growth Rate by Product Technology: 2021 vs 2025 vs 2032
        1.4.2 Bulk/Standard API CDMO
        1.4.3 Specialty API CDMO
    1.5 Market by Application
        1.5.1 Global Chemical API CDMO Market Growth by Application: 2021 vs 2025 vs 2032
        1.5.2 Pharmaceutical and Biotechnology Companies
        1.5.3 Research and Academic Institutions
        1.5.4 Hospital
        1.5.5 Others
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

2 Global Growth Trends
    2.1 Global Chemical API CDMO Market Perspective (2021–2032)
    2.2 Global Chemical API CDMO Growth Trends by Region
        2.2.1 Global Chemical API CDMO Market Size by Region: 2021 vs 2025 vs 2032
        2.2.2 Chemical API CDMO Historic Market Size by Region (2021–2026)
        2.2.3 Chemical API CDMO Forecasted Market Size by Region (2027–2032)
    2.3 Chemical API CDMO Market Dynamics
        2.3.1 Chemical API CDMO Industry Trends
        2.3.2 Chemical API CDMO Market Drivers
        2.3.3 Chemical API CDMO Market Challenges
        2.3.4 Chemical API CDMO Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chemical API CDMO Players by Revenue
        3.1.1 Global Top Chemical API CDMO Players by Revenue (2021–2026)
        3.1.2 Global Chemical API CDMO Revenue Market Share by Players (2021–2026)
    3.2 Global Top Chemical API CDMO Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
    3.3 Global Key Players Ranking by Chemical API CDMO Revenue
    3.4 Global Chemical API CDMO Market Concentration Ratio
        3.4.1 Global Chemical API CDMO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chemical API CDMO Revenue in 2025
    3.5 Global Key Players of Chemical API CDMO Head Offices and Areas Served
    3.6 Global Key Players of Chemical API CDMO, Products and Applications
    3.7 Global Key Players of Chemical API CDMO, Date of General Availability (GA)
    3.8 Mergers and Acquisitions, Expansion Plans

4 Chemical API CDMO Breakdown Data by Type
    4.1 Global Chemical API CDMO Historic Market Size by Type (2021–2026)
    4.2 Global Chemical API CDMO Forecasted Market Size by Type (2027–2032)

5 Chemical API CDMO Breakdown Data by Application
    5.1 Global Chemical API CDMO Historic Market Size by Application (2021–2026)
    5.2 Global Chemical API CDMO Forecasted Market Size by Application (2027–2032)

6 North America
    6.1 North America Chemical API CDMO Market Size (2021–2032)
    6.2 North America Chemical API CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
    6.3 North America Chemical API CDMO Market Size by Country (2021–2026)
    6.4 North America Chemical API CDMO Market Size by Country (2027–2032)
    6.5 United States
    6.6 Canada

7 Europe
    7.1 Europe Chemical API CDMO Market Size (2021–2032)
    7.2 Europe Chemical API CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
    7.3 Europe Chemical API CDMO Market Size by Country (2021–2026)
    7.4 Europe Chemical API CDMO Market Size by Country (2027–2032)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Ireland

8 Asia-Pacific
    8.1 Asia-Pacific Chemical API CDMO Market Size (2021–2032)
    8.2 Asia-Pacific Chemical API CDMO Market Growth Rate by Region: 2021 vs 2025 vs 2032
    8.3 Asia-Pacific Chemical API CDMO Market Size by Region (2021–2026)
    8.4 Asia-Pacific Chemical API CDMO Market Size by Region (2027–2032)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia & New Zealand

9 Latin America
    9.1 Latin America Chemical API CDMO Market Size (2021–2032)
    9.2 Latin America Chemical API CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
    9.3 Latin America Chemical API CDMO Market Size by Country (2021–2026)
    9.4 Latin America Chemical API CDMO Market Size by Country (2027–2032)
    9.5 Mexico
    9.6 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chemical API CDMO Market Size (2021–2032)
    10.2 Middle East & Africa Chemical API CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
    10.3 Middle East & Africa Chemical API CDMO Market Size by Country (2021–2026)
    10.4 Middle East & Africa Chemical API CDMO Market Size by Country (2027–2032)
    10.5 Israel
    10.6 Saudi Arabia
    10.7 UAE

11 Key Players Profiles
    11.1 Flamma Group
        11.1.1 Flamma Group Company Details
        11.1.2 Flamma Group Business Overview
        11.1.3 Flamma Group Chemical API CDMO Introduction
        11.1.4 Flamma Group Revenue in Chemical API CDMO Business (2021–2026)
        11.1.5 Flamma Group Recent Development
    11.2 HAS Healthcare
        11.2.1 HAS Healthcare Company Details
        11.2.2 HAS Healthcare Business Overview
        11.2.3 HAS Healthcare Chemical API CDMO Introduction
        11.2.4 HAS Healthcare Revenue in Chemical API CDMO Business (2021–2026)
        11.2.5 HAS Healthcare Recent Development
    11.3 Asymchem
        11.3.1 Asymchem Company Details
        11.3.2 Asymchem Business Overview
        11.3.3 Asymchem Chemical API CDMO Introduction
        11.3.4 Asymchem Revenue in Chemical API CDMO Business (2021–2026)
        11.3.5 Asymchem Recent Development
    11.4 Recipharm
        11.4.1 Recipharm Company Details
        11.4.2 Recipharm Business Overview
        11.4.3 Recipharm Chemical API CDMO Introduction
        11.4.4 Recipharm Revenue in Chemical API CDMO Business (2021–2026)
        11.4.5 Recipharm Recent Development
    11.5 Pierre Fabre
        11.5.1 Pierre Fabre Company Details
        11.5.2 Pierre Fabre Business Overview
        11.5.3 Pierre Fabre Chemical API CDMO Introduction
        11.5.4 Pierre Fabre Revenue in Chemical API CDMO Business (2021–2026)
        11.5.5 Pierre Fabre Recent Development
    11.6 Pfizer CentreOne
        11.6.1 Pfizer CentreOne Company Details
        11.6.2 Pfizer CentreOne Business Overview
        11.6.3 Pfizer CentreOne Chemical API CDMO Introduction
        11.6.4 Pfizer CentreOne Revenue in Chemical API CDMO Business (2021–2026)
        11.6.5 Pfizer CentreOne Recent Development
    11.7 Axplora
        11.7.1 Axplora Company Details
        11.7.2 Axplora Business Overview
        11.7.3 Axplora Chemical API CDMO Introduction
        11.7.4 Axplora Revenue in Chemical API CDMO Business (2021–2026)
        11.7.5 Axplora Recent Development
    11.8 Lonza
        11.8.1 Lonza Company Details
        11.8.2 Lonza Business Overview
        11.8.3 Lonza Chemical API CDMO Introduction
        11.8.4 Lonza Revenue in Chemical API CDMO Business (2021–2026)
        11.8.5 Lonza Recent Development
    11.9 MAI CDMO
        11.9.1 MAI CDMO Company Details
        11.9.2 MAI CDMO Business Overview
        11.9.3 MAI CDMO Chemical API CDMO Introduction
        11.9.4 MAI CDMO Revenue in Chemical API CDMO Business (2021–2026)
        11.9.5 MAI CDMO Recent Development
    11.10 BioVectra
        11.10.1 BioVectra Company Details
        11.10.2 BioVectra Business Overview
        11.10.3 BioVectra Chemical API CDMO Introduction
        11.10.4 BioVectra Revenue in Chemical API CDMO Business (2021–2026)
        11.10.5 BioVectra Recent Development
    11.11 Curia
        11.11.1 Curia Company Details
        11.11.2 Curia Business Overview
        11.11.3 Curia Chemical API CDMO Introduction
        11.11.4 Curia Revenue in Chemical API CDMO Business (2021–2026)
        11.11.5 Curia Recent Development
    11.12 AGC Pharma Chemicals
        11.12.1 AGC Pharma Chemicals Company Details
        11.12.2 AGC Pharma Chemicals Business Overview
        11.12.3 AGC Pharma Chemicals Chemical API CDMO Introduction
        11.12.4 AGC Pharma Chemicals Revenue in Chemical API CDMO Business (2021–2026)
        11.12.5 AGC Pharma Chemicals Recent Development
    11.13 Asymchem
        11.13.1 Asymchem Company Details
        11.13.2 Asymchem Business Overview
        11.13.3 Asymchem Chemical API CDMO Introduction
        11.13.4 Asymchem Revenue in Chemical API CDMO Business (2021–2026)
        11.13.5 Asymchem Recent Development
    11.14 Olon Group
        11.14.1 Olon Group Company Details
        11.14.2 Olon Group Business Overview
        11.14.3 Olon Group Chemical API CDMO Introduction
        11.14.4 Olon Group Revenue in Chemical API CDMO Business (2021–2026)
        11.14.5 Olon Group Recent Development
    11.15 Evonik Health Care
        11.15.1 Evonik Health Care Company Details
        11.15.2 Evonik Health Care Business Overview
        11.15.3 Evonik Health Care Chemical API CDMO Introduction
        11.15.4 Evonik Health Care Revenue in Chemical API CDMO Business (2021–2026)
        11.15.5 Evonik Health Care Recent Development
    11.16 Teva Active Pharmaceutical Ingredients
        11.16.1 Teva Active Pharmaceutical Ingredients Company Details
        11.16.2 Teva Active Pharmaceutical Ingredients Business Overview
        11.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Introduction
        11.16.4 Teva Active Pharmaceutical Ingredients Revenue in Chemical API CDMO Business (2021–2026)
        11.16.5 Teva Active Pharmaceutical Ingredients Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Chemical API CDMO Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Small Molecule CDMO
 Table 3. Key Players of Macromolecule CDMO
 Table 4. Key Players of Cell Gene Therapy (CGT) CDMO
 Table 5. Global Chemical API CDMO Market Size Growth Rate by Business Stage (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Key Players of Early-stage R&D CDMO
 Table 7. Key Players of Clinical Stage CDMO
 Table 8. Key Players of Commercial Production CDMO
 Table 9. Global Chemical API CDMO Market Size Growth Rate by Product Technology (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Key Players of Bulk/Standard API CDMO
 Table 11. Key Players of Specialty API CDMO
 Table 12. Global Chemical API CDMO Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 13. Global Chemical API CDMO Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 14. Global Chemical API CDMO Market Size by Region (US$ Million), 2021–2026
 Table 15. Global Chemical API CDMO Market Share by Region (2021–2026)
 Table 16. Global Chemical API CDMO Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 17. Global Chemical API CDMO Market Share by Region (2027–2032)
 Table 18. Chemical API CDMO Market Trends
 Table 19. Chemical API CDMO Market Drivers
 Table 20. Chemical API CDMO Market Challenges
 Table 21. Chemical API CDMO Market Restraints
 Table 22. Global Chemical API CDMO Revenue by Players (US$ Million), 2021–2026
 Table 23. Global Chemical API CDMO Market Share by Players (2021–2026)
 Table 24. Global Top Chemical API CDMO Players by Tier (Tier 1, Tier 2, and Tier 3), based on Chemical API CDMO Revenue, 2025
 Table 25. Ranking of Global Top Chemical API CDMO Companies by Revenue (US$ Million) in 2025
 Table 26. Global 5 Largest Players Market Share by Chemical API CDMO Revenue (CR5 and HHI), 2021–2026
 Table 27. Global Key Players of Chemical API CDMO, Headquarters and Area Served
 Table 28. Global Key Players of Chemical API CDMO, Products and Applications
 Table 29. Global Key Players of Chemical API CDMO, Date of General Availability (GA)
 Table 30. Mergers and Acquisitions, Expansion Plans
 Table 31. Global Chemical API CDMO Market Size by Type (US$ Million), 2021–2026
 Table 32. Global Chemical API CDMO Revenue Market Share by Type (2021–2026)
 Table 33. Global Chemical API CDMO Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 34. Global Chemical API CDMO Revenue Market Share by Type (2027–2032)
 Table 35. Global Chemical API CDMO Market Size by Application (US$ Million), 2021–2026
 Table 36. Global Chemical API CDMO Revenue Market Share by Application (2021–2026)
 Table 37. Global Chemical API CDMO Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 38. Global Chemical API CDMO Revenue Market Share by Application (2027–2032)
 Table 39. North America Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 40. North America Chemical API CDMO Market Size by Country (US$ Million), 2021–2026
 Table 41. North America Chemical API CDMO Market Size by Country (US$ Million), 2027–2032
 Table 42. Europe Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Europe Chemical API CDMO Market Size by Country (US$ Million), 2021–2026
 Table 44. Europe Chemical API CDMO Market Size by Country (US$ Million), 2027–2032
 Table 45. Asia-Pacific Chemical API CDMO Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Asia-Pacific Chemical API CDMO Market Size by Region (US$ Million), 2021–2026
 Table 47. Asia-Pacific Chemical API CDMO Market Size by Region (US$ Million), 2027–2032
 Table 48. Latin America Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 49. Latin America Chemical API CDMO Market Size by Country (US$ Million), 2021–2026
 Table 50. Latin America Chemical API CDMO Market Size by Country (US$ Million), 2027–2032
 Table 51. Middle East & Africa Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 52. Middle East & Africa Chemical API CDMO Market Size by Country (US$ Million), 2021–2026
 Table 53. Middle East & Africa Chemical API CDMO Market Size by Country (US$ Million), 2027–2032
 Table 54. Flamma Group Company Details
 Table 55. Flamma Group Business Overview
 Table 56. Flamma Group Chemical API CDMO Product
 Table 57. Flamma Group Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 58. Flamma Group Recent Development
 Table 59. HAS Healthcare Company Details
 Table 60. HAS Healthcare Business Overview
 Table 61. HAS Healthcare Chemical API CDMO Product
 Table 62. HAS Healthcare Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 63. HAS Healthcare Recent Development
 Table 64. Asymchem Company Details
 Table 65. Asymchem Business Overview
 Table 66. Asymchem Chemical API CDMO Product
 Table 67. Asymchem Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 68. Asymchem Recent Development
 Table 69. Recipharm Company Details
 Table 70. Recipharm Business Overview
 Table 71. Recipharm Chemical API CDMO Product
 Table 72. Recipharm Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 73. Recipharm Recent Development
 Table 74. Pierre Fabre Company Details
 Table 75. Pierre Fabre Business Overview
 Table 76. Pierre Fabre Chemical API CDMO Product
 Table 77. Pierre Fabre Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 78. Pierre Fabre Recent Development
 Table 79. Pfizer CentreOne Company Details
 Table 80. Pfizer CentreOne Business Overview
 Table 81. Pfizer CentreOne Chemical API CDMO Product
 Table 82. Pfizer CentreOne Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 83. Pfizer CentreOne Recent Development
 Table 84. Axplora Company Details
 Table 85. Axplora Business Overview
 Table 86. Axplora Chemical API CDMO Product
 Table 87. Axplora Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 88. Axplora Recent Development
 Table 89. Lonza Company Details
 Table 90. Lonza Business Overview
 Table 91. Lonza Chemical API CDMO Product
 Table 92. Lonza Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 93. Lonza Recent Development
 Table 94. MAI CDMO Company Details
 Table 95. MAI CDMO Business Overview
 Table 96. MAI CDMO Chemical API CDMO Product
 Table 97. MAI CDMO Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 98. MAI CDMO Recent Development
 Table 99. BioVectra Company Details
 Table 100. BioVectra Business Overview
 Table 101. BioVectra Chemical API CDMO Product
 Table 102. BioVectra Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 103. BioVectra Recent Development
 Table 104. Curia Company Details
 Table 105. Curia Business Overview
 Table 106. Curia Chemical API CDMO Product
 Table 107. Curia Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 108. Curia Recent Development
 Table 109. AGC Pharma Chemicals Company Details
 Table 110. AGC Pharma Chemicals Business Overview
 Table 111. AGC Pharma Chemicals Chemical API CDMO Product
 Table 112. AGC Pharma Chemicals Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 113. AGC Pharma Chemicals Recent Development
 Table 114. Asymchem Company Details
 Table 115. Asymchem Business Overview
 Table 116. Asymchem Chemical API CDMO Product
 Table 117. Asymchem Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 118. Asymchem Recent Development
 Table 119. Olon Group Company Details
 Table 120. Olon Group Business Overview
 Table 121. Olon Group Chemical API CDMO Product
 Table 122. Olon Group Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 123. Olon Group Recent Development
 Table 124. Evonik Health Care Company Details
 Table 125. Evonik Health Care Business Overview
 Table 126. Evonik Health Care Chemical API CDMO Product
 Table 127. Evonik Health Care Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 128. Evonik Health Care Recent Development
 Table 129. Teva Active Pharmaceutical Ingredients Company Details
 Table 130. Teva Active Pharmaceutical Ingredients Business Overview
 Table 131. Teva Active Pharmaceutical Ingredients Chemical API CDMO Product
 Table 132. Teva Active Pharmaceutical Ingredients Revenue in Chemical API CDMO Business (US$ Million), 2021–2026
 Table 133. Teva Active Pharmaceutical Ingredients Recent Development
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources
 Table 137. Authors List of This Report


List of Figures
 Figure 1. Chemical API CDMO Picture
 Figure 2. Global Chemical API CDMO Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Chemical API CDMO Market Share by Type: 2025 vs 2032
 Figure 4. Small Molecule CDMO Features
 Figure 5. Macromolecule CDMO Features
 Figure 6. Cell Gene Therapy (CGT) CDMO Features
 Figure 7. Global Chemical API CDMO Market Size Comparison by Business Stage (US$ Million), 2021–2032
 Figure 8. Early-stage R&D CDMO Features
 Figure 9. Clinical Stage CDMO Features
 Figure 10. Commercial Production CDMO Features
 Figure 11. Global Chemical API CDMO Market Size Comparison by Product Technology (US$ Million), 2021–2032
 Figure 12. Bulk/Standard API CDMO Features
 Figure 13. Specialty API CDMO Features
 Figure 14. Global Chemical API CDMO Market Size by Application (US$ Million), 2021–2032
 Figure 15. Global Chemical API CDMO Market Share by Application: 2025 vs 2032
 Figure 16. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 17. Research and Academic Institutions Case Studies
 Figure 18. Hospital Case Studies
 Figure 19. Others Case Studies
 Figure 20. Chemical API CDMO Report Years Considered
 Figure 21. Global Chemical API CDMO Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 22. Global Chemical API CDMO Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global Chemical API CDMO Market Share by Region: 2025 vs 2032
 Figure 24. Global Chemical API CDMO Market Share by Players in 2025
 Figure 25. Global Chemical API CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 26. The Top 10 and 5 Players Market Share by Chemical API CDMO Revenue in 2025
 Figure 27. North America Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. North America Chemical API CDMO Market Share by Country (2021–2032)
 Figure 29. United States Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Canada Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Europe Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Europe Chemical API CDMO Market Share by Country (2021–2032)
 Figure 33. Germany Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. France Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. U.K. Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Italy Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Russia Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Ireland Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Asia-Pacific Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Asia-Pacific Chemical API CDMO Market Share by Region (2021–2032)
 Figure 41. China Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Japan Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. South Korea Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Southeast Asia Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. India Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Australia & New Zealand Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Latin America Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Latin America Chemical API CDMO Market Share by Country (2021–2032)
 Figure 49. Mexico Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Brazil Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Middle East & Africa Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Middle East & Africa Chemical API CDMO Market Share by Country (2021–2032)
 Figure 53. Israel Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 55. UAE Chemical API CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. Flamma Group Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 57. HAS Healthcare Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 58. Asymchem Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 59. Recipharm Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 60. Pierre Fabre Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 61. Pfizer CentreOne Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 62. Axplora Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 63. Lonza Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 64. MAI CDMO Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 65. BioVectra Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 66. Curia Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 67. AGC Pharma Chemicals Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 68. Asymchem Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 69. Olon Group Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 70. Evonik Health Care Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 71. Teva Active Pharmaceutical Ingredients Revenue Growth Rate in Chemical API CDMO Business (2021–2026)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed

Description

The global Chemical API CDMO market was valued at US$ 27700 million in 2025 and is anticipated to reach US$ 46080 million by 2032, at a CAGR of 7.6% from 2026 to 2032.

Chemical API CDMO, or Contract Research and Manufacturing Organization, provides pharmaceutical companies with customized R&D and manufacturing services for active pharmaceutical ingredients (APIs) and related intermediates from preclinical to commercialization stages. Its services encompass process route development and optimization, analytical method establishment and validation, pilot-scale and intermediate-scale production, process safety assessment, and support for large-scale production and registration applications in compliance with Good Manufacturing Practices (GMP). This model, through specialized division of labor, helps clients reduce R&D costs, shorten development cycles, address the challenges of complex chemical synthesis and production scale-up, and ensure supply chain reliability and compliance. It is a key enabling link in the supply chain for innovative chemical drugs and complex generic drugs.

Market Segmentation

Related Reports

Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Chemical API CDMO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 95
USD 3950.00
(Single User License)
Global Chemical API CDMO Market Research Report 2024
The global Chemical API CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 76
USD 2900.00
(Single User License)
Global Chemical API CDMO Market Research Report 2025
The global market for Chemical API CDMO was valued at US$ 25750 million in the year 2024 and is projected to reach a revised size of US$ 43109 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published: 2025-12-12
Pages: 137
USD 2900.00
(Single User License)
Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chemical API CDMO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 92
USD 3950.00
(Single User License)
Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chemical API CDMO market is projected to grow from US$ 25750 million in 2024 to US$ 43109 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 152
USD 4900.00
(Single User License)
Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chemical API CDMO market size was US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 104
USD 4250.00
(Single User License)
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chemical API CDMO was estimated to be worth US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 136
USD 3950.00
(Single User License)
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chemical API CDMO was estimated to be worth US$ 27700 million in 2025 and is projected to reach US$ 46080 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 125
USD 3950.00
(Single User License)
Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chemical API CDMO market size was US$ 27700 million in 2025 and is forecast to reach a readjusted size of US$ 46080 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 109
USD 4250.00
(Single User License)
Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chemical API CDMO market is projected to grow from US$ 27700 million in 2025 to US$ 46080 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 151
USD 4900.00
(Single User License)

Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Chemical API CDMO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 95
USD 3950.00 ()
Global Chemical API CDMO Market Research Report 2024
The global Chemical API CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 76
USD 2900.00 ()
Global Chemical API CDMO Market Research Report 2025
The global market for Chemical API CDMO was valued at US$ 25750 million in the year 2024 and is projected to reach a revised size of US$ 43109 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published: 2025-12-12
Pages: 137
USD 2900.00 ()
Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chemical API CDMO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 92
USD 3950.00 ()
Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chemical API CDMO market is projected to grow from US$ 25750 million in 2024 to US$ 43109 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 152
USD 4900.00 ()
Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chemical API CDMO market size was US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 104
USD 4250.00 ()
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chemical API CDMO was estimated to be worth US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 136
USD 3950.00 ()
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chemical API CDMO was estimated to be worth US$ 27700 million in 2025 and is projected to reach US$ 46080 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 125
USD 3950.00 ()
Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chemical API CDMO market size was US$ 27700 million in 2025 and is forecast to reach a readjusted size of US$ 46080 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 109
USD 4250.00 ()
Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chemical API CDMO market is projected to grow from US$ 27700 million in 2025 to US$ 46080 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 151
USD 4900.00 ()